Evolus Valuation

EOLS Stock  USD 4.29  0.01  0.23%   
At this time, the firm appears to be undervalued. Evolus Inc shows a prevailing Real Value of $6.84 per share. The current price of the firm is $4.29. Our model computes the value of Evolus Inc from reviewing the firm fundamentals such as Current Valuation of 389.45 M, shares outstanding of 64.82 M, and Profit Margin of (0.20) % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Evolus' valuation include:
Price Book
53.7058
Enterprise Value
389.4 M
Enterprise Value Ebitda
(21.50)
Price Sales
0.9729
Forward PE
142.8571
Undervalued
Today
4.29
Please note that Evolus' price fluctuation is slightly risky at this time. Calculation of the real value of Evolus Inc is based on 3 months time horizon. Increasing Evolus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Evolus stock is determined by what a typical buyer is willing to pay for full or partial control of Evolus Inc. Since Evolus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evolus Stock. However, Evolus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.29 Real  6.84 Target  15.17 Hype  4.28 Naive  4.23
The intrinsic value of Evolus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Evolus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
6.84
Real Value
10.02
Upside
Estimating the potential upside or downside of Evolus Inc helps investors to forecast how Evolus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evolus more accurately as focusing exclusively on Evolus' fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-0.04-0.020.01
Details
Hype
Prediction
LowEstimatedHigh
1.104.287.46
Details
Naive
Forecast
LowNext ValueHigh
1.054.237.41
Details
7 Analysts
Consensus
LowTarget PriceHigh
13.8015.1716.84
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Evolus' intrinsic value based on its ongoing forecasts of Evolus' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Evolus' closest peers.

Evolus Cash

72.57 Million

Evolus Total Value Analysis

Evolus Inc is currently expected to have valuation of 389.45 M with market capitalization of 278.08 M, debt of 129.98 M, and cash on hands of 84.48 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Evolus fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
389.45 M
278.08 M
129.98 M
84.48 M

Evolus Investor Information

About 17.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.9. Evolus Inc had not issued any dividends in recent years. Based on the key indicators related to Evolus' liquidity, profitability, solvency, and operating efficiency, Evolus Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Evolus Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Evolus has an asset utilization ratio of 114.49 percent. This implies that the Company is making $1.14 for each dollar of assets. An increasing asset utilization means that Evolus Inc is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid
 
Interest Hikes

Evolus Profitability Analysis

Based on Evolus' profitability indicators, Evolus Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess Evolus' ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2015-12-31
Previous Quarter
-17.1 M
Current Value
-15.7 M
Quarterly Volatility
17.7 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Gross Profit is likely to gain to about 220.1 M in 2026, whereas Pretax Profit Margin is likely to drop (0.18) in 2026.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.740.79
Notably Down
Slightly volatile
For Evolus profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Evolus Inc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Evolus utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Evolus's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Evolus over time as well as its relative position and ranking within its peers.

Evolus Earnings per Share Projection vs Actual

The next projected EPS of Evolus is estimated to be -0.01625 with future projections ranging from a low of -0.0425 to a high of 0.01. Evolus' most recent 12-month trailing earnings per share (EPS TTM) is at -0.9. Please be aware that the consensus of earnings estimates for Evolus Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Evolus is projected to generate -0.01625 in earnings per share on the 31st of December 2026. Evolus earnings estimates show analyst consensus about projected Evolus EPS (Earning Per Share). It derives the highest and the lowest estimates based on Evolus' historical volatility. Many public companies, such as Evolus, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Evolus Earnings Estimation Breakdown

The calculation of Evolus' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Evolus is estimated to be -0.01625 with the future projection ranging from a low of -0.0425 to a high of 0.01. Please be aware that this consensus of annual earnings estimates for Evolus Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
-0.04
Lowest
Expected EPS
-0.01625
0.01
Highest

Evolus Earnings Projection Consensus

Suppose the current estimates of Evolus' value are higher than the current market price of the Evolus stock. In this case, investors may conclude that Evolus is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Evolus' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2026Current EPS (TTM)
767.42%
0.0
-0.01625
-0.9

Evolus Ownership Allocation

Evolus holds a total of 64.82 Million outstanding shares. The majority of Evolus Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Evolus Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Evolus. Please pay attention to any change in the institutional holdings of Evolus Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Evolus Profitability Analysis

The company reported the previous year's revenue of 266.27 M. Net Loss for the year was (50.42 M) with profit before overhead, payroll, taxes, and interest of 190.45 M.

About Evolus Valuation

The stock valuation mechanism determines Evolus' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Evolus Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Evolus. We calculate exposure to Evolus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Evolus's related companies.
Last ReportedProjected for Next Year
Gross Profit209.6 M220.1 M
Pretax Profit Margin(0.17)(0.18)
Operating Profit Margin(0.13)(0.12)
Net Loss(0.17)(0.18)
Gross Profit Margin 0.79  0.74 

Evolus Growth Indicators

Investing in growth stocks can be very risky. If the company such as Evolus does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding62 M
Forward Price Earnings142.8571

Evolus Current Valuation Indicators

Evolus' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Evolus' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Evolus, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Evolus' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Evolus' worth.

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.